Two immunotherapy drugs could be better than one - at least for a subset of patients with advanced melanoma.
Researchers have developed an experimental treatment to overcome resistance to drugs used to treat cancers of the blood.
A long-term follow up of people on a clinical trial has confirmed the benefit of immunotherapy for some patients with advanced melanoma.
Cancer Research UK, Cancer Research Technology and Amgen to trial leukaemia immunotherapy drug in other cancers
Cancer Research UK, Cancer Research Technology and Amgen to trial leukaemia immunotherapy drug in patients with soild tuimours.
Can you help a research team grow 3D lung tissue in a lab to help study cancer? Can we track how moving skin cancer cells give the immune system the slip? Or is there a...
We’ve come a long way from the early days of treating cancer in the 1950s and 60s. Back then, the main options for treatment were relatively unrefined radiotherapy and...
Treating cancers with immunotherapy and radiotherapy at the same time could stop them from becoming resistant to treatment.
Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.